Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: clinical and angiographic outcomes
BS George,
WD Voorhees 3rd,
GS Roubin,
NE Fearnot,
CA Pinkerton,
AE Raizner,
SB King,
DR Holmes,
EJ Topol,
DJ Kereiakes,
et al.
Mid-Ohio Cardiology Research Foundation, Riverside Methodist Hospital, Columbus.
OBJECTIVES. This study reports on the initial experience with the Gianturco-Roubin flexible coronary stent. The immediate and 6-month efficacy of the device and the incidence of the complications of death, myocardial infarction, emergency coronary artery bypass surgery and recurrent ischemic events are presented. BACKGROUND. Abrupt or threatened vessel closure after coronary angioplasty is associated with increased risk of myocardial infarction, emergency coronary artery bypass graft surgery and in-hospital death. When dissection or prolapse of dilated plaque into the lumen is unresponsive to additional or prolonged balloon catheter inflation, coronary stenting offers a nonsurgical mechanical means to rapidly restore stable vessel geometry and adequate coronary blood flow. METHODS. From September 1988 through June 1991, 518 patients underwent attempted coronary stenting with the 20-mm long Gianturco-Roubin coronary stent for acute or threatened vessel closure after angioplasty. In 494 patients, one or more stents were deployed. Thirty-two percent of patients received stents for acute closure and 69% for threatened closure. RESULTS. Successful deployment was achieved in 95.4% of patients. Overall, stenting resulted in an immediate angiographic improvement in the diameter stenosis from 63 +/- 25% before stenting to 15 +/- 14% after stenting. Emergency coronary artery bypass graft surgery was required in 4.3% (21 of 493 patients). The incidence of in-hospital myocardial infarction (Q wave and non-Q wave) was 5.5% (27 of 493 patients). At 6 months, myocardial infarction was infrequent, occurring in 1.6% (8 of 493 patients). The incidence of in-hospital death was 2.2% (11 of 493 patients). Late death occurred in 7 patients (1.4%) and 34 patients (6.9%) required later bypass graft surgery. Complications included blood loss, primarily from the arterial access site, and subacute thrombosis of the stented vessel in 43 patients (8.7%). CONCLUSIONS. The early multicenter experience suggests that this stent is a useful adjunct to coronary angioplasty to prevent or minimize complications associated with flow-limiting coronary artery dissections previously correctable only by surgery. Although this study was not randomized, it demonstrated a high technical success rate and encouraging results with respect to the low incidence of emergency coronary artery bypass graft surgery and myocardial infarction.
This article has been cited by other articles:

|
 |

|
 |
 
B. J. Doyle, H. H. Ting, M. R. Bell, R. J. Lennon, V. Mathew, M. Singh, D. R. Holmes, and C. S. Rihal
Major Femoral Bleeding Complications After Percutaneous Coronary Intervention: Incidence, Predictors, and Impact on Long-Term Survival Among 17,901 Patients Treated at the Mayo Clinic From 1994 to 2005
J. Am. Coll. Cardiol. Intv.,
April 1, 2008;
1(2):
202 - 209.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Wilson and J. T. Willerson
Myocardial Revascularization with Percutaneous Devices
Card. Surg. Adult,
January 1, 2008;
3(2008):
573 - 598.
[Full Text]
|
 |
|

|
 |

|
 |
 
N. Inami, S. Nomura, T. Kajiura, K. Yamada, H. Nakamori, N. Takahashi, N. Tsuda, S. Fukuhara, and T. Iwasaka
Significance of {alpha}IIb{beta}3 in Subacute Stent ThrombosisAfter Percutaneous Coronary Intervention
Clinical and Applied Thrombosis/Hemostasis,
October 1, 2005;
11(4):
455 - 459.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
G. De Luca, H. Suryapranata, R. Grimaldi, and M. Chiariello
Coronary stenting and abciximab in primary angioplasty for ST-segment-elevation myocardial infarction
QJM,
September 1, 2005;
98(9):
633 - 641.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Batyraliev, M. R. Ayalp, A. Sercelik, Z. Karben, G. Dinler, F. Besnili, S. Ozgul, and I. Perchucov
Complications of Cardiac Catheterization: A Single-Center Study
Angiology,
January 1, 2005;
56(1):
75 - 80.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Colombo, G. Stankovic, and J. W. Moses
Selection of coronary stents
J. Am. Coll. Cardiol.,
September 18, 2002;
40(6):
1021 - 1033.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Johansson, H. Olsson, and B. Wennerblom
Angiography-Guided Routine Coronary Stent Implantation Results in Suboptimal Dilatation
Angiology,
January 1, 2002;
53(1):
69 - 75.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Cutlip, D. S. Baim, K. K. L. Ho, J. J. Popma, A. J. Lansky, D. J. Cohen, J. P. Carrozza Jr, M. S. Chauhan, O. Rodriguez, and R. E. Kuntz
Stent Thrombosis in the Modern Era : A Pooled Analysis of Multicenter Coronary Stent Clinical Trials
Circulation,
April 17, 2001;
103(15):
1967 - 1971.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Al Suwaidi, P. B. Berger, and D. R. Holmes Jr
Coronary Artery Stents
JAMA,
October 11, 2000;
284(14):
1828 - 1836.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. J. Cantor, E. D. Peterson, J. J. Popma, J. P. Zidar, M. H. Sketch Jr., J. E. Tcheng, and E. M. Ohman
Provisional stenting strategies: systematic overview and implications for clinical decision-making
J. Am. Coll. Cardiol.,
October 1, 2000;
36(4):
1142 - 1151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Bertrand, H.-J. Rupprecht, P. Urban, A. H. Gershlick, and f. t. C. Investigators
Double-Blind Study of the Safety of Clopidogrel With and Without a Loading Dose in Combination With Aspirin Compared With Ticlopidine in Combination With Aspirin After Coronary Stenting : The Clopidogrel Aspirin Stent International Cooperative Study (CLASSICS)
Circulation,
August 8, 2000;
102(6):
624 - 629.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Alexopoulos, C. Stefanadis, C. Olympios, V. Voudris, S. Hatzimiltiadis, D. Sionis, E. Vavouranakis, A. Vrahatis, C. Fakiolas, E. Pissimisis, et al.
Antiplatelet Is Superior to Anticoagulant Treatment After Coronary Stenting: Fewer Coronary and Other Events Within 30 Days After Stenting
Angiology,
April 1, 2000;
51(4):
289 - 294.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Malenka, P. D. McGrath, D. E. Wennberg, T. J. Ryan Jr., M. A. Kellett Jr, S. J. Shubrooks Jr., W. A. Bradley, B. D. Hettlemen, J. F. Robb, M. J. Hearne, et al.
The relationship between operator volume and outcomes after percutaneous coronary interventions in high volume hospitals in 1994-1996: The northern New England experience
J. Am. Coll. Cardiol.,
November 1, 1999;
34(5):
1471 - 1480.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. L. Lazar, Y. Bao, D. Lancaster, O. M. Shapira, G. S. Aldea, and R. J. Shemin
Favorable impact of stents after emergent coronary artery bypass for failed angioplasty
Ann. Thorac. Surg.,
November 1, 1999;
68(5):
1644 - 1647.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. S. Weintraub, S. Culler, S. J. Boccuzzi, J. R. Cook, A. S. Kosinski, D. J. Cohen, J. Burnette, and for the RESTORE Trial Study Group
Economic impact of GPIIB/IIIA blockade after high-risk angioplasty: Results from the restore trial
J. Am. Coll. Cardiol.,
October 1, 1999;
34(4):
1061 - 1066.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Salachas, S. P. Patsilinakos, K. P. Tsilias, I. Stefanou, N. G. Margaris, G. P. Ifantis, A. J. Kranidis, A. G. Tavernarakis, S. G. Rokas, and I. Antonellis
Elective Intracoronary Micro-Stent IITM Implantation Without Quantitative Coronary Angiography or Intravascular Ultrasound Guidance and Without Subsequent Anticoagulation: Short- and Long-Term Results
Angiology,
May 1, 1999;
50(5):
381 - 391.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P B M Clarkson, M Halim, K K Ray, S Doshi, M Been, H Singh, and M F Shiu
Coronary artery stenting in unstable angina pectoris: a comparison with stable angina pectoris
Heart,
April 1, 1999;
81(4):
393 - 397.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. N. Piana, W. H. Ahmed, B. Chaitman, P. Ganz, S. Kinlay, J. Strony, B. Adelman, J. A. Bittl, and on behalf of the Hirulog Angioplasty Study Investi
Effect of transient abrupt vessel closure during otherwise successful angioplasty for unstable angina on clinical outcome at six months
J. Am. Coll. Cardiol.,
January 1, 1999;
33(1):
73 - 78.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Holmes Jr., J. Hirshfeld Jr., D. Faxon, R. Vlietstra, A. Jacobs, S. B. King III, T. M. Bashore, N. D. Bridges, C. B. Higgins, L. F. Hiratzka, et al.
ACC expert consensus document on coronary artery stents: Document of the American College of Cardiology
J. Am. Coll. Cardiol.,
November 1, 1998;
32(5):
1471 - 1482.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Topol and P. W. Serruys
Frontiers in Interventional Cardiology
Circulation,
October 27, 1998;
98(17):
1802 - 1820.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kastrati, F.-J. Neumann, and A. Schomig
Operator volume and outcome of patients undergoing coronary stent placement
J. Am. Coll. Cardiol.,
October 1, 1998;
32(4):
970 - 976.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y Yoshitomi, S Kojima, T Sugi, M Yano, Y Matsumoto, and M Kuramochi
Antiplatelet treatment with cilostazol after stent implantation
Heart,
October 1, 1998;
80(4):
393 - 396.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Yavuz, T. Bozat, H. Vural, O. Tiryakioglu, T. Turk, N. Ayabakan, C. Eris, V. Koca, and I A. Ozdemir
Stent Entrapment in Ostium of Left Main Coronary Artery: Emergency Surgical Removal
Asian Cardiovasc Thorac Ann,
September 1, 1998;
6(3):
240 - 241.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Schuhlen, A. Kastrati, J. Dirschinger, J. Hausleiter, S. Elezi, A. Wehinger, J. Pache, M. Hadamitzky, and A. Schomig
Intracoronary Stenting and Risk for Major Adverse Cardiac Events During the First Month
Circulation,
July 14, 1998;
98(2):
104 - 111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K K HAASE, A BAUMBACH, and K R KARSCH
Stents are used too often
Heart,
June 1, 1998;
79(6):
541 - 542.
[Full Text]
|
 |
|

|
 |

|
 |
 
C. R. Narins, D. R. Holmes Jr, and E. J. Topol
A Call for Provisional Stenting : The Balloon Is Back!
Circulation,
April 7, 1998;
97(13):
1298 - 1305.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Rodes, G. Cote, J. Lesperance, M. G. Bourassa, S. Doucet, L. Bilodeau, O. F. Bertrand, F. Harel, R. Gallo, and J.-C. Tardif
Prevention of Restenosis After Angioplasty in Small Coronary Arteries With Probucol
Circulation,
February 10, 1998;
97(5):
429 - 436.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. V. Anderson, R. E. Jordan, and H. F. Weisman
Concept and Clinical Application of Platelet Glycoprotein IIb/IIIa Inhibition with Abciximab (c7E3 Fab; ReoPro) for the Prevention of Acute Ischemic Syndromes
Clinical and Applied Thrombosis/Hemostasis,
October 1, 1997;
3(4):
256 - 266.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. D. Kugelmass and G. E. Raskob
Antithrombotic Therapy in Patients Undergoing Coronary Angioplasty or Coronary Stent Placement
Clinical and Applied Thrombosis/Hemostasis,
October 1, 1997;
3(1_suppl):
S24 - S31.
[PDF]
|
 |
|

|
 |

|
 |
 
H. Schuhlen, M. Hadamitzky, H. Walter, K. Ulm, and A. Schomig
Major Benefit From Antiplatelet Therapy for Patients at High Risk for Adverse Cardiac Events After Coronary Palmaz-Schatz Stent Placement : Analysis of a Prospective Risk Stratification Protocol in the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial
Circulation,
April 15, 1997;
95(8):
2015 - 2021.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. Albiero, P. Hall, A. Itoh, S. Blengino, S. Nakamura, G. Martini, M. Ferraro, and A. Colombo
Results of a Consecutive Series of Patients Receiving Only Antiplatelet Therapy After Optimized Stent Implantation: Comparison of Aspirin Alone Versus Combined Ticlopidine and Aspirin Therapy
Circulation,
March 4, 1997;
95(5):
1145 - 1156.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. B. Schneider and D. A. Dichek
Intravascular Stent Endothelialization: A Goal Worth Pursuing?
Circulation,
January 21, 1997;
95(2):
308 - 310.
[Full Text]
|
 |
|

|
 |

|
 |
 
N. G Uren and N. A. Chronos
Intracoronary stents
BMJ,
October 12, 1996;
313(7062):
892 - 893.
[Full Text]
|
 |
|

|
 |

|
 |
 
G. J. Karrillon, M. C. Morice, E. Benveniste, P. Bunouf, P. Aubry, S. Cattan, B. Chevalier, P. Commeau, A. Cribier, C. Eiferman, et al.
Intracoronary Stent Implantation Without Ultrasound Guidance and With Replacement of Conventional Anticoagulation by Antiplatelet Therapy: 30-Day Clinical Outcome of the French Multicenter Registry
Circulation,
October 1, 1996;
94(7):
1519 - 1527.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Sheth, F. Litvack, V. Dev, M. C. Fishbein, J. S. Forrester, and N. Eigler
Subacute Thrombosis and Vascular Injury Resulting From Slotted-Tube Nitinol and Stainless Steel Stents in a Rabbit Carotid Artery Model
Circulation,
October 1, 1996;
94(7):
1733 - 1740.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. N. Ruygrok and P. W. Serruys
Intracoronary Stenting: From Concept to Custom
Circulation,
September 1, 1996;
94(5):
882 - 890.
[Full Text]
|
 |
|

|
 |

|
 |
 
Y. Ozaki, D. Keane, P. Ruygrok, W. J. van der Giessen, P. de Feyter, and P. W. Serruys
Six-Month Clinical and Angiographic Outcome of the New, Less Shortening Wallstent in Native Coronary Arteries
Circulation,
June 15, 1996;
93(12):
2114 - 2120.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. M. Goods, K. F. Al-Shaibi, S. S. Yadav, M. W. Liu, B. H. Negus, S. S. Iyer, L. S. Dean, S. P. Jain, W. A. Baxley, J. M. Parks, et al.
Utilization of the Coronary Balloon-Expandable Coil Stent Without Anticoagulation or Intravascular Ultrasound
Circulation,
May 15, 1996;
93(10):
1803 - 1808.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. O. Williams
Dressing Up the Palmaz-Schatz Stent
Circulation,
February 1, 1996;
93(3):
400 - 402.
[Full Text]
|
 |
|

|
 |

|
 |
 
P. Hall, S. Nakamura, L. Maiello, A. Itoh, S. Blengino, G. Martini, M. Ferraro, and A. Colombo
A Randomized Comparison of Combined Ticlopidine and Aspirin Therapy Versus Aspirin Therapy Alone After Successful Intravascular Ultrasound Guided Stent Implantation
Circulation,
January 15, 1996;
93(2):
215 - 222.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. G. Ellis, D. P. Miller, K. J. Brown, N. Omoigui, G. L. Howell, M. Kutner, and E. J. Topol
In-Hospital Cost of Percutaneous Coronary Revascularization : Critical Determinants and Implications
Circulation,
August 15, 1995;
92(4):
741 - 747.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. M. Craver, A. G. Justicz, W. S. Weintraub, Y. Shen, R. A. Guyton, J. P. Gott, and E. L. Jones
Coronary artery bypass grafting in patients after failure of intracoronary stenting
Ann. Thorac. Surg.,
July 1, 1995;
60(1):
60 - 66.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
F. V. Aguirre, E. J. Topol, J. J. Ferguson, K. Anderson, J. C. Blankenship, R. R. Heuser, K. Sigmon, M. Taylor, R. Gottlieb, G. Hanovich, et al.
Bleeding Complications With the Chimeric Antibody to Platelet Glycoprotein IIb/IIIa Integrin in Patients Undergoing Percutaneous Coronary Intervention
Circulation,
June 15, 1995;
91(12):
2882 - 2890.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. Rogers and E. R. Edelman
Endovascular Stent Design Dictates Experimental Restenosis and Thrombosis
Circulation,
June 15, 1995;
91(12):
2995 - 3001.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Colombo, P. Hall, S. Nakamura, Y. Almagor, L. Maiello, G. Martini, A. Gaglione, S. L. Goldberg, and J. M. Tobis
Intracoronary Stenting Without Anticoagulation Accomplished With Intravascular Ultrasound Guidance
Circulation,
March 15, 1995;
91(6):
1676 - 1688.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L Corr
Fortnightly Review: New methods of making blocked coronary arteries patent again
BMJ,
September 3, 1994;
309(6954):
579 - 583.
[Full Text]
|
 |
|

|
 |

|
 |
 
STENTS FOR VESSEL CLOSURE AFTER PTCA
Journal Watch (General),
July 9, 1993;
1993(709):
3 - 3.
[Full Text]
|
 |
|
|